沐舒坦雾化吸入治疗老年慢性支气管炎急性发作50例疗效观察

Clinical observation of Ambroxol aerosol inhalation in treatment of 50 elderly patients with acute exacerbation of chronic bronchitis

目的探讨沐舒坦雾化吸入治疗老年慢性支气管炎急性发作临床效果。方法选择100例老年慢性支气管炎急性发作患者,随机分为观察组和对照组。对照组和观察组均给予常规治疗。对照组给予庆大霉素、地塞米松和α糜蛋白联合雾化吸入,观察组组给予沐舒坦雾化吸入。结果观察组总有效率为96.0%,对照组总有效率78.0%,观察组总有效率显著高于对照组,差异有统计学意义(P<0.05)。结论沐舒坦雾化吸入能够显著改善老年慢性支气管炎急性发作的临床症状和体征,临床效果,值得借鉴。

Objective To explore the clinical efficacy of Ambroxol aerosol inhalation on onelderly patients with acute exacerbation of chronic bronchitis. Methods 100 elderly patients with acute exacerbation of chronic bronchitis were selected and randomly divided into observation group and control group. The routine therapy was used to two groups. The control group was given gentamycin, dexamethasone and a - chymotrypsin combined atomization inhalation, the observation group were given Mucosolvan aerosol inhalation. Results The total efficiency in observation group after treatment was 96. 0%, The total efficiency in control group after treatment was78.0%. The total effective rate in observation group were significantly higher than those of control group, the difference was statistically significant （ P 〈 0. 05 ）. Conclusion Ambroxol aerosol inhalation can significantly improve the clinical symptoms and signs of elderly patients of acute exacerbation of chronic bronchitis, clinical efficacy is significant,and the therapy is worthy of reference.